customer service software
0

Global 3D Printed Drugs Market

  • Published Date: 25 Mar 2019
  • Number of Pages: 300
  • Category: Healthcare and Medical
  • Country: Global
Global 3D Printed Drugs Market size was valued at US$ 245 Mn in 2017 and is expected to reach US$ 456 Mn by 2026 to exhibit a CAGR of 8.07 % during a forecast period.



3D printed technology for medicines is an innovative and cost-saving technology to deliver medications with easiness. 3D printed drugs are used to develop medications with controlled release of drugs, and those containing fixed-dose combinations.

The bonding of powdered materials between liquid materials to generate 3D printed drugs, makes the formulations very permeable to fluids. 3D printed drugs dissolve as soon as when they come into contact with a small quantity of liquid. This helps controlling medications to children, physically impaired patients as well as those patients who are suffering from seizures.

The key factors enhancing the growth of market are the technological innovations in 3D printing procedures, the instant solubility of the drug in the mouth, and an increasing number of epilepsy patients. Epilepsy is a disorder in which nerve cell activity in the brain is disturbed, causing seizures like symptoms of a brain problem. However, blueprint hacking and mislabelling of blueprint is expected to hamper the growth of the market. Moreover, dicey regulatory scenario is another major restraint.

Growing adoption of new generation 3D printing technology, rising technological advancement and spending on research and development by the top pharmaceutical companies such as GlaxoSmithKline are boosting the growth of 3D printed drug market. However, dearth of government regulations related to 3D printed drugs and adverse effects of 3D printed drugs are expected to hinder the growth of the market.

Aprecia Company successfully developed the worlds first 3D printed drug known as Spritam. Aprecia has gained approval from the food & drug administration and is on sale in the U.S market at present.

Asia Pacific is leading share of 34.1% in the 3D printed drugs market and expected to witness lucrative growth and registering a CAGR of 18.2% during the forecast period. Rapid development of healthcare infrastructure and growing investment in research and development of healthcare sector are projected to boost the growth of 3D printed drugs market in Asia Pacific region. Asia Pacific countries such as China & India are expected to grow at the highest rate in the 3D printed drugs market in few years, due to massive investments in both R&D as well as the pharmaceutical industry. Europe region is also projected to witness satisfactory growth during the forecast period, owing to the growing health consciousness among people of Europe region.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding global 3D printed drugs market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, report also focuses on competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTERs analysis, SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in near future to emerging segment in global 3D printed drugs market.
The Scope of Global 3D Printed Drugs Market:
Global 3D Printed Drugs Market, By Scenario:
Low Growth Scenario
Moderate Growth Scenario
Rapid Growth Scenario
Global 3D Printed Drugs Market, By End User:
Hospitals
Clinics
Research Laboratories
Other
Global 3D Printed Drugs Market, By Region:
North America
Europe
Middle East & Africa
Asia Pacific
South America
The Key Players Operating In the Global 3D Printed Drugs Market:
Aprecia
Extend Biosciences
Bioduro
Affinity Therapeutics
Osmotica Pharmaceuticals
Acrux
Thiomatrix
Ico Therapeutics Inc.
Formac Pharmaceuticals
BiopharmX
Pacira Pharmaceuticals Inc.
3D Printer Drug Machine
FabRx Ltd.
GlaxoSmithKline Plc.
Hewlett Packard Caribe
BV, LLC
Publisher Name : Maximize Market Research
Global 3D printed drugs market
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources

3. Executive Summary: Global 3D Printed Drugs Market Size, by Market Value (US$ Mn) and Market Volume (Units)

4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porters Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies inGlobal 3D Printed Drugs Market
4.8. Patent Registration

5. Supply Side and Demand Side Indicators

6. Global 3D Printed Drugs Market Analysis and Forecast
6.1. Global 3D Printed Drugs Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global 3D Printed Drugs Market Analysis and Forecast, by Scenario
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global 3D Printed Drugs Market Value Share Analysis, by Scenario
7.4. Global 3D Printed Drugs Market Size (US$ Mn) Forecast, by Scenario
7.5. Global 3D Printed Drugs Market Analysis, by Scenario
7.6. Global 3D Printed Drugs Market Attractiveness Analysis, by Scenario

8. Global 3D Printed Drugs Market Analysis and Forecast, by End User
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global 3D Printed Drugs Market Value Share Analysis, by End User
8.4. Global 3D Printed Drugs Market Size (US$ Mn) Forecast, by End User
8.5. Global 3D Printed Drugs Market Analysis, by End User
8.6. Global 3D Printed Drugs Market Attractiveness Analysis, by End User

9. Global 3D Printed Drugs Market Analysis, by Region
9.1. Global 3D Printed Drugs Market Value Share Analysis, by Region
9.2. Global 3D Printed Drugs Market Size (US$ Mn) Forecast, by Region
9.3. Global 3D Printed Drugs Market Attractiveness Analysis, by Region

10. North America 3D Printed Drugs Market Analysis
10.1. Key Findings
10.2. North America 3D Printed Drugs Market Overview
10.3. North America 3D Printed Drugs Market Value Share Analysis, by Scenario
10.4. North America 3D Printed Drugs Market Forecast, by Scenario
10.4.1. Low Growth Scenario
10.4.2. Moderate Growth Scenario
10.4.3. Rapid Growth Scenario
10.5. North America 3D Printed Drugs Market Value Share Analysis, by End User
10.6. North America 3D Printed Drugs Market Forecast, by End User
10.6.1. Hospitals
10.6.2. Clinics
10.6.3. Research Laboratories
10.6.4. Other
10.7. North America 3D Printed Drugs Market Value Share Analysis, by Country
10.8. North America 3D Printed Drugs Market Forecast, by Country
10.8.1. U.S.
10.8.2. Canada
10.9. North America 3D Printed Drugs Market Analysis, by Country
10.10. U.S. 3D Printed Drugs Market Forecast, by Scenario
10.10.1. Low Growth Scenario
10.10.2. Moderate Growth Scenario
10.10.3. Rapid Growth Scenario
10.11. U.S. 3D Printed Drugs Market Forecast, by End User
10.11.1. Hospitals
10.11.2. Clinics
10.11.3. Research Laboratories
10.11.4. Other
10.12. Canada 3D Printed Drugs Market Forecast, by Scenario
10.12.1. Low Growth Scenario
10.12.2. Moderate Growth Scenario
10.12.3. Rapid Growth Scenario
10.13. Canada 3D Printed Drugs Market Forecast, by End User
10.13.1. Hospitals
10.13.2. Clinics
10.13.3. Research Laboratories
10.13.4. Other
10.14. North America 3D Printed Drugs Market Attractiveness Analysis
10.14.1. By Scenario
10.14.2. By End User
10.15. PEST Analysis
10.16. Key Trends
10.17. Key Developments

11. Europe 3D Printed Drugs Market Analysis
11.1. Key Findings
11.2. Europe 3D Printed Drugs Market Overview
11.3. Europe 3D Printed Drugs Market Value Share Analysis, by Scenario
11.4. Europe 3D Printed Drugs Market Forecast, by Scenario
11.4.1. Low Growth Scenario
11.4.2. Moderate Growth Scenario
11.4.3. Rapid Growth Scenario
11.5. Europe 3D Printed Drugs Market Value Share Analysis, by End User
11.6. Europe 3D Printed Drugs Market Forecast, by End User
11.6.1. Hospitals
11.6.2. Clinics
11.6.3. Research Laboratories
11.6.4. Other
11.7. Europe 3D Printed Drugs Market Value Share Analysis, by Country
11.8. Europe 3D Printed Drugs Market Forecast, by Country
11.8.1. Germany
11.8.2. U.K.
11.8.3. France
11.8.4. Italy
11.8.5. Spain
11.8.6. Rest of Europe
11.9. Europe 3D Printed Drugs Market Analysis, by Country
11.10. Germany 3D Printed Drugs Market Forecast, by Scenario
11.10.1. Low Growth Scenario
11.10.2. Moderate Growth Scenario
11.10.3. Rapid Growth Scenario
11.11. Germany 3D Printed Drugs Market Forecast, by End User
11.11.1. Hospitals
11.11.2. Clinics
11.11.3. Research Laboratories
11.11.4. Other
11.12. U.K. 3D Printed Drugs Market Forecast, by Scenario
11.12.1. Low Growth Scenario
11.12.2. Moderate Growth Scenario
11.12.3. Rapid Growth Scenario
11.13. U.K. 3D Printed Drugs Market Forecast, by End User
11.13.1. Hospitals
11.13.2. Clinics
11.13.3. Research Laboratories
11.13.4. Other
11.14. France 3D Printed Drugs Market Forecast, by Scenario
11.14.1. Low Growth Scenario
11.14.2. Moderate Growth Scenario
11.14.3. Rapid Growth Scenario
11.15. France 3D Printed Drugs Market Forecast, by End User
11.15.1. Hospitals
11.15.2. Clinics
11.15.3. Research Laboratories
11.15.4. Other
11.16. Italy 3D Printed Drugs Market Forecast, by Scenario
11.16.1. Low Growth Scenario
11.16.2. Moderate Growth Scenario
11.16.3. Rapid Growth Scenario
11.17. Italy 3D Printed Drugs Market Forecast, by End User
11.17.1. Hospitals
11.17.2. Clinics
11.17.3. Research Laboratories
11.17.4. Other
11.18. Spain 3D Printed Drugs Market Forecast, by Scenario
11.18.1. Low Growth Scenario
11.18.2. Moderate Growth Scenario
11.18.3. Rapid Growth Scenario
11.19. Spain 3D Printed Drugs Market Forecast, by End User
11.19.1. Hospitals
11.19.2. Clinics
11.19.3. Research Laboratories
11.19.4. Other
11.20. Rest of Europe 3D Printed Drugs Market Forecast, by Scenario
11.20.1. Low Growth Scenario
11.20.2. Moderate Growth Scenario
11.20.3. Rapid Growth Scenario
11.21. Rest of Europe 3D Printed Drugs Market Forecast, by End User
11.21.1. Hospitals
11.21.2. Clinics
11.21.3. Research Laboratories
11.21.4. Other
11.22. Europe 3D Printed Drugs Market Attractiveness Analysis
11.22.1. By Scenario
11.22.2. By End User
11.23. PEST Analysis
11.24. Key Trends
11.25. Key Developments

12. Asia Pacific 3D Printed Drugs Market Analysis
12.1. Key Findings
12.2. Asia Pacific 3D Printed Drugs Market Overview
12.3. Asia Pacific 3D Printed Drugs Market Value Share Analysis, by Scenario
12.4. Asia Pacific 3D Printed Drugs Market Forecast, by Scenario
12.4.1. Low Growth Scenario
12.4.2. Moderate Growth Scenario
12.4.3. Rapid Growth Scenario
12.5. Asia Pacific 3D Printed Drugs Market Value Share Analysis, by End User
12.6. Asia Pacific 3D Printed Drugs Market Forecast, by End User
12.6.1. Hospitals
12.6.2. Clinics
12.6.3. Research Laboratories
12.6.4. Other
12.7. Asia Pacific 3D Printed Drugs Market Value Share Analysis, by Country
12.8. Asia Pacific 3D Printed Drugs Market Forecast, by Country
12.8.1. China
12.8.2. India
12.8.3. Japan
12.8.4. ASEAN
12.8.5. Rest of Asia Pacific
12.9. Asia Pacific 3D Printed Drugs Market Analysis, by Country
12.10. China 3D Printed Drugs Market Forecast, by Scenario
12.10.1. Low Growth Scenario
12.10.2. Moderate Growth Scenario
12.10.3. Rapid Growth Scenario
12.11. China 3D Printed Drugs Market Forecast, by End User
12.11.1. Hospitals
12.11.2. Clinics
12.11.3. Research Laboratories
12.11.4. Other
12.12. India 3D Printed Drugs Market Forecast, by Scenario
12.12.1. Low Growth Scenario
12.12.2. Moderate Growth Scenario
12.12.3. Rapid Growth Scenario
12.13. India 3D Printed Drugs Market Forecast, by End User
12.13.1. Hospitals
12.13.2. Clinics
12.13.3. Research Laboratories
12.13.4. Other
12.14. Japan 3D Printed Drugs Market Forecast, by Scenario
12.14.1. Low Growth Scenario
12.14.2. Moderate Growth Scenario
12.14.3. Rapid Growth Scenario
12.15. Japan 3D Printed Drugs Market Forecast, by End User
12.15.1. Hospitals
12.15.2. Clinics
12.15.3. Research Laboratories
12.15.4. Other
12.16. ASEAN 3D Printed Drugs Market Forecast, by Scenario
12.16.1. Low Growth Scenario
12.16.2. Moderate Growth Scenario
12.16.3. Rapid Growth Scenario
12.17. ASEAN 3D Printed Drugs Market Forecast, by End User
12.17.1. Hospitals
12.17.2. Clinics
12.17.3. Research Laboratories
12.17.4. Other
12.18. Rest of Asia Pacific 3D Printed Drugs Market Forecast, by Scenario
12.18.1. Low Growth Scenario
12.18.2. Moderate Growth Scenario
12.18.3. Rapid Growth Scenario
12.19. Rest of Asia Pacific 3D Printed Drugs Market Forecast, by End User
12.19.1. Hospitals
12.19.2. Clinics
12.19.3. Research Laboratories
12.19.4. Other
12.20. Asia Pacific 3D Printed Drugs Market Attractiveness Analysis
12.20.1. By Scenario
12.20.2. By End User
12.21. PEST Analysis
12.22. Key Trends
12.23. Key Developments

13. Middle East & Africa 3D Printed Drugs Market Analysis
13.1. Key Findings
13.2. Middle East & Africa 3D Printed Drugs Market Overview
13.3. Middle East & Africa 3D Printed Drugs Market Value Share Analysis, by Scenario
13.4. Middle East & Africa 3D Printed Drugs Market Forecast, by Scenario
13.4.1. Low Growth Scenario
13.4.2. Moderate Growth Scenario
13.4.3. Rapid Growth Scenario
13.5. Middle East & Africa 3D Printed Drugs Market Value Share Analysis, by End User
13.6. Middle East & Africa 3D Printed Drugs Market Forecast, by End User
13.6.1. Hospitals
13.6.2. Clinics
13.6.3. Research Laboratories
13.6.4. Other
13.7. Middle East & Africa 3D Printed Drugs Market Value Share Analysis, by Country
13.8. Middle East & Africa 3D Printed Drugs Market Forecast, by Country
13.8.1. GCC
13.8.2. South Africa
13.8.3. Rest of Middle East & Africa
13.9. Middle East & Africa 3D Printed Drugs Market Analysis, by Country
13.10. GCC 3D Printed Drugs Market Forecast, by Scenario
13.10.1. Low Growth Scenario
13.10.2. Moderate Growth Scenario
13.10.3. Rapid Growth Scenario
13.11. GCC 3D Printed Drugs Market Forecast, by End User
13.11.1. Hospitals
13.11.2. Clinics
13.11.3. Research Laboratories
13.11.4. Other
13.12. South Africa 3D Printed Drugs Market Forecast, by Scenario
13.12.1. Low Growth Scenario
13.12.2. Moderate Growth Scenario
13.12.3. Rapid Growth Scenario
13.13. South Africa 3D Printed Drugs Market Forecast, by End User
13.13.1. Hospitals
13.13.2. Clinics
13.13.3. Research Laboratories
13.13.4. Other
13.14. Rest of Middle East & Africa 3D Printed Drugs Market Forecast, by Scenario
13.14.1. Low Growth Scenario
13.14.2. Moderate Growth Scenario
13.14.3. Rapid Growth Scenario
13.15. Rest of Middle East & Africa 3D Printed Drugs Market Forecast, by End User
13.15.1. Hospitals
13.15.2. Clinics
13.15.3. Research Laboratories
13.15.4. Other
13.16. Middle East & Africa 3D Printed Drugs Market Attractiveness Analysis
13.16.1. By Scenario
13.16.2. By End User
13.17. PEST Analysis
13.18. Key Trends
13.19. Key Developments

14. South America 3D Printed Drugs Market Analysis
14.1. Key Findings
14.2. South America 3D Printed Drugs Market Overview
14.3. South America 3D Printed Drugs Market Value Share Analysis, by Scenario
14.4. South America 3D Printed Drugs Market Forecast, by Scenario
14.4.1. Low Growth Scenario
14.4.2. Moderate Growth Scenario
14.4.3. Rapid Growth Scenario
14.5. South America 3D Printed Drugs Market Value Share Analysis, by End User
14.6. South America 3D Printed Drugs Market Forecast, by End User
14.6.1. Hospitals
14.6.2. Clinics
14.6.3. Research Laboratories
14.6.4. Other
14.7. South America 3D Printed Drugs Market Value Share Analysis, by Country
14.8. South America 3D Printed Drugs Market Forecast, by Country
14.8.1. Brazil
14.8.2. Mexico
14.8.3. Rest of South America
14.9. South America 3D Printed Drugs Market Analysis, by Country
14.10. Brazil 3D Printed Drugs Market Forecast, by Scenario
14.10.1. Low Growth Scenario
14.10.2. Moderate Growth Scenario
14.10.3. Rapid Growth Scenario
14.11. Brazil 3D Printed Drugs Market Forecast, by End User
14.11.1. Hospitals
14.11.2. Clinics
14.11.3. Research Laboratories
14.11.4. Other
14.12. Mexico 3D Printed Drugs Market Forecast, by Scenario
14.12.1. Low Growth Scenario
14.12.2. Moderate Growth Scenario
14.12.3. Rapid Growth Scenario
14.13. Mexico 3D Printed Drugs Market Forecast, by End User
14.13.1. Hospitals
14.13.2. Clinics
14.13.3. Research Laboratories
14.13.4. Other
14.14. Rest of South America 3D Printed Drugs Market Forecast, by Scenario
14.14.1. Low Growth Scenario
14.14.2. Moderate Growth Scenario
14.14.3. Rapid Growth Scenario
14.15. Rest of South America 3D Printed Drugs Market Forecast, by End User
14.15.1. Hospitals
14.15.2. Clinics
14.15.3. Research Laboratories
14.15.4. Other
14.16. South America 3D Printed Drugs Market Attractiveness Analysis
14.16.1. By Scenario
14.16.2. By End User
14.17. PEST Analysis
14.18. Key Trends
14.19. Key Developments

15. Company Profiles
15.1. Market Share Analysis, by Company
15.2. Competition Matrix
15.2.1. Competitive Benchmarking of key players by price, presence, market share, Application and R&D investment
15.2.2. New Product Launches and Product Enhancements
15.2.3. Market Consolidation
15.2.3.1. M&A by Regions, Investment and Application
15.2.3.2. M&A Key Players, Forward Integration and Backward
Integration
15.3. Company Profiles: Key Players
15.3.1. Aprecia
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategy
15.3.1.5. Recent Developments
15.3.1.6. Manufacturing Footprint
15.3.2. Extend Biosciences
15.3.3. Bioduro
15.3.4. Affinity Therapeutics
15.3.5. Osmotica Pharmaceuticals
15.3.6. Acrux
15.3.7. Thiomatrix
15.3.8. Ico Therapeutics Inc.
15.3.9. Formac Pharmaceuticals
15.3.10. BiopharmX
15.3.11. Pacira Pharmaceuticals Inc.
15.3.12. 3D Printer Drug Machine
15.3.13. FabRx Ltd.
15.3.14. GlaxoSmithKline Plc.
15.3.15. Hewlett Packard Caribe
15.3.16. BV, LLC

16. Primary Key Insights

The global market size of Human Platelet Lysate is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the

View Report

The global market size of Human Parainfluenza Viruses Diagnostics is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by

View Report

The global market size of Human Papillomavirus Hpv Testing is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)